Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-14

Clinical Trial Update: Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing local heat therapy to sodium stibogluconate for cutaneous leishmaniasis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Local heat therapy
  • Sodium stibogluconate (sodium stibogluconate)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Cutaneous Leishmaniasis | Phase 2 | Status: COMPLETED | Results posted: 2017-07-14